BioCorRx Inc. (BICX)
OTCMKTS · Delayed Price · Currency is USD
0.2980
0.00 (0.00%)
Aug 6, 2026, 9:30 AM EST

BioCorRx Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.880.80.010.090.210.05
Revenue Growth
531.11%10301.10%-91.40%-58.30%342.99%-60.63%
Gross Profit
0.830.780.010.050.20.04
Operating Income
-4.84-4.83-5.12-3.74-4.7-5.37
Net Income
-3.43-3.44-5.11-3.77-4.37-5.28
Earnings Per Share
-0.16-0.19-0.49-0.45-0.61-0.81
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.210.140.090.070.070.09
Total Debt
2.162.142.811.811.681.65
Net Cash (Debt)
-1.94-2-2.72-1.75-1.61-1.57
Net Cash Growth
------
Net Cash Per Share
-0.09-0.11-0.26-0.21-0.22-0.24

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-2.04-2.3-1.1-1.85-2.04-3.54
Capital Expenditures
------0
Free Cash Flow
-2.04-2.3-1.1-1.85-2.04-3.54
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
94.64%97.27%78.25%59.64%92.86%87.82%
Operating Margin
-552.33%-606.04%-66829.81%-4194.50%-2196.96%-11121.62%
Pretax Margin
-401.07%-440.11%-67998.72%-4228.90%-2046.77%-10794.33%
Profit Margin
-391.15%-431.51%-66616.10%-4224.89%-2043.30%-10934.66%
FCF Margin
-232.83%-288.28%-14302.07%-2078.60%-954.81%-7332.77%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
9.878.87649.4475.7534.95600.27